These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Drug evaluation: PSN-9301, a short-acting inhibitor of dipeptidyl peptidase IV.
    Author: Epstein BJ.
    Journal: Curr Opin Investig Drugs; 2007 Apr; 8(4):331-7. PubMed ID: 17458184.
    Abstract:
    (OSI) Prosidion is developing PSN-9301, a rationally designed dipeptidyl peptidase IV inhibitor acquired from Probiodrug AG, as a potential oral treatment for type 2 diabetes. Phase II clinical trials of PSN-9301 are underway.
    [Abstract] [Full Text] [Related] [New Search]